• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Tips for Good Medication Practice

Tips for Good Medication Practice

May 1, 2018
Mark Chenven, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Mark Chenven, MDMark Chenven, MD Private practice child and adolescent psychiatrist, San Diego, CA Dr. Chenven has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Good practice using psychotropic medications with children and adolescents requires a psychiatrist to pay attention to a number of elements. The following are some recommendations from child psychiatrist Mark Chenven, MD, of the things you should observe and the rules you might want to follow while prescribing medications:

  • Start low, go slow: Most side effects are dose-related, so gradual up-titration is simple common sense. This allows for the body’s homeostatic and regulatory mechanisms to respond gradually and reduces the severity of emerging side effects. With this approach, a favorable clinical response may also be achieved for some patients at lower than standard dosing.

  • One step at a time: Making one change at a time is another sound practice, as this allows you to monitor the impact of each changed variable. An exception to this rule would be a situation where you are cross-titrating between two agents and/or dealing with a clinically complex problematic situation. But overall, the math of “less is more” applies to the medication change agenda.

  • Consider weekend trials: Starting a new medication or making a significant dosage adjustment over the weekend affords parents and the child or teen the opportunity to monitor for both efficacy and side effects.

  • Seek feedback: Requesting parents or the older adolescent/young adult patient to call with any emerging concerns and scheduling timely follow-up visits further enhances our ability to understand and respond to medication impacts.

  • Longitudinal follow-through is key: Ongoing routine inquiry about side effects and monitoring relevant vital signs is a core practice expectation. Also, routine should be recognition of co-occurring health conditions and coordination of care with the youth’s pediatric physician.

  • Focus on med compliance: Compliance and noncompliance should be reviewed periodically. Use longer-acting agents (eg, fluoxetine) when appropriate, and work with kids and parents on developing more consistent medication use habits.

  • Review and reconsider: Recognizing the failure of a medication to achieve desired results needs to be considered, and it should trigger a reassessment of the diagnosis and treatment plan. A medication without appreciable and definable benefit probably needs to be set aside.

  • Reject fads: With newly marketed agents, it’s better to be the tortoise than the hare. It is safer for patients to be a late adopter than to pursue the cutting edge.

  • Beware of polypharmacy: Multiple agents raise the risk of side effects. Combinations can have therapeutic benefits, but it is important to reassess the efficacy of all agents monitored for side effects, interactions, and other challenges.

  • Pay heed to second thoughts: When in doubt, get a second opinion—either from a trusted colleague or through a more formal request for patient-centered consultation.

  • Monitor sleep patterns: Disturbances of sleep should be addressed behaviorally when possible, and pharmacologically when warranted. Ask about them.

  • Inquire about herbals and OTC agents: Many patients and parents think that herbals, supplements, and “natural” remedies are benign. Ask, or you may never be told. Learn more about these agents, and work with families and youth to make mutual decisions on whether to continue them.

  • Ask about cannabis use: Whether the teen (or younger child!) is using it on the sly or the parent is administering it, inquiring about cannabis is increasingly important. Research will catch up eventually, but absence of evidence does not mean absence of efficacy. Dialog with your patients and their families and, for now, recommend against cannabis use.

  • Check for other substances: These include alcohol, methamphetamine, psychedelics, heroin, or use of grandma’s codeine, sleeping pills, SSRIs, etc. These substances may be misused, so ask, discuss, and intervene wisely.

  • Learn about life changes: Inquire about other changes in the child’s life—parental discord, changes in the family structure (eg, siblings off to college), new or lost friends, changes in school, illnesses, accidents, bullying, or all the other things that can upset the apple cart. Any of them may impact our patients’ functioning.

Child Psychiatry
KEYWORDS child-psychiatry pharmacology-tips
    Ccpr mayj psych qa chenven photo 150x150
    Mark Chenven, MD

    Considerations When Prescribing Psychotropic Medications

    More from this author
    www.thecarlatreport.com
    Issue Date: May 1, 2018
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Psychotropic Risks in Children and Adolescents, CCPR, May/June 2018
    Informed Consent: An Ongoing Process for Focused Care
    Embracing Conflict in the Consent Process
    Considerations When Prescribing Psychotropic Medications
    Metformin to Control Antipsychotic-Induced Weight Gain in Children
    Tips for Good Medication Practice
    Youth, Antidepressant Medications, and Type 2 Diabetes
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.